Bixiye
QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 221 - 230 ee natiijooyinka 3562
Bixiye
QP63-25 MHCP Pharmacy Benefit Exclusion for Enflonsia™, Lynozyfic™ and Zusduri™
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP61-25 Change in Replacement Claim Processing
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP45R1-25 Multiple Medicaid Coverages Listed on the Same Claim
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP68-25 MHCP Process for Behavioral Health Residential Prior Authorization (PA) Submission
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP97-25 Medicare Advantage Membership Transition in 2026
Taariikhda uu dhaqangalayo Barnaamijka: Nov 12, 2025
Bixiye
QP96-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Nov 12, 2025
Bixiye
QP95-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2026
Taariikhda uu dhaqangalayo Barnaamijka: Nov 12, 2025
Bixiye
QP94-25 MHCP Pharmacy Benefit Exclusion for Inlexzo™, Keytruda Qlex™, Tyruko® and Yimmugo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 12, 2025